Czechia, April 29 -- Czechia based AbbVie s.r.o. has secured contract from Institut klinicke a experimentalni mediciny for Immunosuppressive agents - selective immunosuppressants - risankizumab i. The value of the contract is worth 1810542460 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....